Azelaic acid

Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azelaic acid?

Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azelaic acid

PubChem Associated disorders and diseases

What pathways are associated with Azelaic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azelaic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azelaic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azelaic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azelaic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azelaic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Azelaic acid

Download all related citations
Per page 10 20 50 100 | Total 511
Authors Title Published Journal PubMed Link
Rodríguez Prieto MA et al. Treatment of lentigo maligna with azelaic acid. 1993 Int. J. Dermatol. pmid:8505164
Banerjee S et al. 2'-(3 alpha-Benzyloxy-24-norcholan-23-yl)-2',4',4'-trimethyl-4',5'- dihydrooxazoline-N-oxyl as a potential spin probe for model membranes. 1994 Steroids pmid:7940616
Pattarino F et al. Topical delivery systems for azelaic acid: effect of the suspended drug in microemulsion. 1994 Pharmazie pmid:8140138
Ferioli V et al. Determination of azelaic acid in pharmaceuticals and cosmetics by RP-HPLC after pre-column derivatization. 1994 Farmaco pmid:8074784
Bojar RA et al. Disruption of the transmembrane pH gradient--a possible mechanism for the antibacterial action of azelaic acid in Propionibacterium acnes and Staphylococcus epidermidis. 1994 J. Antimicrob. Chemother. pmid:7829407
Nguyen QH and Bui TP Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. 1995 Int. J. Dermatol. pmid:7737781
U-Taniguchi Y et al. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. 1995 Oncol. Res. pmid:8555652
Grimes PE Melasma. Etiologic and therapeutic considerations. 1995 Arch Dermatol pmid:7492140
Lemic-Stojcevic L et al. Effect of azelaic acid on melanoma cells in culture. 1995 Exp. Dermatol. pmid:7640879
Gatti R et al. Analysis of aliphatic dicarboxylic acids in pharmaceuticals and cosmetics by liquid chromatography (HPLC) with fluorescence detection. 1995 J Pharm Biomed Anal pmid:9696574
Addo-Boadu K et al. Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro. 1996 Cancer Lett. pmid:8635147
Azelaic acid-a new topical drug for acne. 1996 Med Lett Drugs Ther pmid:8637482
Gibson JR Rationale for the development of new topical treatments for acne vulgaris. 1996 Cutis pmid:8654127
Graupe K et al. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. 1996 Cutis pmid:8654128
Breathnach AS Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. 1996 Cutis pmid:8654129
Lowe NJ New approaches in dermatology: a clinical profile of azelaic acid. 1996 Cutis pmid:8654130
Nazzaro-Porro M et al. A case of recurrent (following surgery x2) invasive malignant melanoma with satellitosis (stage IIIA) successfully resolving after azelaic acid treatment administered by several routes. 1996 Clin. Exp. Dermatol. pmid:8959915
Mackrides PS and Shaughnessy AF Azelaic acid therapy for acne. 1996 Am Fam Physician pmid:8961845
Rodriguez-Vicente J et al. Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines. 1996 Pigment Cell Res. pmid:9125756
Oh CW and Myung KB An ultrastructural study of the retention hyperkeratosis of experimentally induced comedones in rabbits: the effects of three comedolytics. 1996 J. Dermatol. pmid:8935627
Jansen T and Plewig G Advances and perspectives in acne therapy. 1997 Eur. J. Med. Res. pmid:9262484
Parsons PG et al. Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells. 1997 Biochem. Pharmacol. pmid:9264325
Gibson JR Azelaic acid 20% cream (AZELEX) and the medical management of acne vulgaris. 1997 Dermatol Nurs pmid:9392765
Rodriguez-Vicente J et al. The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines. 1998 Cancer pmid:9452267
Usatine RP et al. Acne vulgaris: a treatment update. 1998 Hosp Pract (1995) pmid:9484299
Gollnick H and Schramm M Topical drug treatment in acne. 1998 Dermatology (Basel) pmid:9557245
Gollnick H and Schramm M Topical therapy in acne. 1998 J Eur Acad Dermatol Venereol pmid:9891903
Spellman MC and Pincus SH Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne. 1998 Jul-Aug Clin Ther pmid:9737831
Lowe NJ et al. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. 1998 Sep-Oct Clin Ther pmid:9829446
Kakita LS and Lowe NJ Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. 1998 Sep-Oct Clin Ther pmid:9829447
Bjerke R et al. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. 1999 Acta Derm. Venereol. pmid:10598760
Capristo E et al. A new HPLC method for the direct analysis of triglycerides of dicarboxylic acids in biological samples. 1999 Clin. Chim. Acta pmid:10556649
Breathnach AS Azelaic acid: potential as a general antitumoural agent. 1999 Med. Hypotheses pmid:10362281
Rocamora V et al. Amelanotic lentigo maligna melanoma: report of a case and review of the literature. 1999 Cutis pmid:10431675
Maddin S A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. 1999 J. Am. Acad. Dermatol. pmid:10365928
Hermanns JF et al. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. 2000 Dermatology (Basel) pmid:11053913
Korman SH et al. Characteristic urine organic acid profile in peroxisomal biogenesis disorders. 2000 J. Inherit. Metab. Dis. pmid:10896310
Webster G Combination azelaic acid therapy for acne vulgaris. 2000 J. Am. Acad. Dermatol. pmid:10898830
Russell JJ Topical therapy for acne. 2000 Am Fam Physician pmid:10670502
Thiboutot D New treatments and therapeutic strategies for acne. 2000 Arch Fam Med pmid:10693736
Usatine RP The science and art of treating acne in adolescence. 2000 West. J. Med. pmid:10734805
Malaisse WJ et al. Effects of aliphatic dioic acids and glycerol-1,2,3-tris(dodecanedioate) on D-glucose-stimulated insulin release in rat pancreatic islets. 2000 Br. J. Nutr. pmid:11177188
Gutheil WG Application of hierarchical thermodynamic interactions to the protonation equilibria of organic polyprotic acids. 2000 Biophys. Chem. pmid:11152269
Pérez-Bernal A et al. Management of facial hyperpigmentation. 2000 Sep-Oct Am J Clin Dermatol pmid:11702317
Koczorek M ["Cleansing, topical treatment, oral administration". Controlling acne]. 2001 MMW Fortschr Med pmid:11524979
Gollnick HP et al. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. 2001 Nov-Dec Eur J Dermatol pmid:11701404
Brune TG et al. Unknown peaks in GC-MS analyses of Guthrie cards blood samples might be the result of sample contamination by the black markings of the card. 2002 J. Inherit. Metab. Dis. pmid:12555947
Del Rosso JQ A status report on the medical management of rosacea: focus on topical therapies. 2002 Cutis pmid:12469780
Hojo Y et al. Fluid shear stress attenuates hydrogen peroxide-induced c-Jun NH2-terminal kinase activation via a glutathione reductase-mediated mechanism. 2002 Circ. Res. pmid:12386148
Ruan H et al. Structure of a novel diterpenoid ester, fritillahupehin from bulbs of Fritillaria hupehensis Hsiao and K.C. Hsia. 2002 Fitoterapia pmid:12234570